past Speaks
A
Alexander Gaffney
PwC Health Research Institute
Andy Li
Founding Partner
Biosense Global LLC
Anjiang (Vincent) Liu
Senior Advisor, Fosun Pharma
Aamir Shahzad
President
European Society for Translational Medicine
Ai-Min Hui (TBD)
CMO, Fosun Pharma
Alan Jiang
XtalPi
Anna Vardanyan
Executive Director, Business Development and Alliance Management
Aaron Chen
Senior Director, Global Business Development & Licensing, Oncology, Bayer Pharmaceuticals
Atul Deshpande Ph.D., MBA, PMP
Chief Strategy Officer & Head, US
Operations; Executive Director Board of Directors, HBM
Adam Zhao
Founding Partner, Anlong Fund; CEO, Anlong Bio
Amy Tang
Venture Partner, Qiming Venture
Partners
Andrew Radin
CEO,
twoXAR
Managing Director,
NxR Biotechnologies
GmbH
B
Bernice Ma
Associate Principal
Evolution Road LLC
Bob Ai
Senior Vice President, Solebury Trout (Moderator)
Brad Loncar
CEO
Loncar Investments
Brian Yang
Ben Zhao
Founder&President
Haichang Biotech
Bin Chen
Bo Liu
Executive VP &
Managing DirectorHealthcare Investments,
CDIB Capital
Bing Yuan
Chief Business Officer,
Cstone Pharmaceuticals
C
Chong Xu
Senior Associate, F-Prime Capital Partners
Christian Soschner
CS Life Science Invest
Csaba Wolf
Deloitte
Cynthia Cai
Senior Advisor, Northern Light Venture Capital
Chanmei Chen
Executive Deputy Director of
Nanjing Municipal Jiangbei New Area Administrative Committee
Calvin Chen
CEO of CrossLinkBio,Inc.
D
Dan Zhang
President
European Society for Translational Medicine
Danhui Wang
Managing Partner
Remedeca Partners LLC
Daniel Chai
Managing Partner, Turret Capital Management
Darren Ji
Partner, Lily Asia Ventures
Dayong Wang
PathAI
Dennis Purcell
Derrick Li
Cellular Biomedicine Group
Dianna Qian
Partner
Pivotal bioVenture Partners China
Dong Chen
Director and China head of business development
Jiangsu Hengrui Pharmaceutical
Derrick Li
Cellular Biomedicine Group
Dong Liu
CEO, Kind
Pharmaceutical
Dr.Dan Liu
Senior Partner
CDH Fund
Dr Pavel Peng
Director
InnoPinnacle Fund
Dr. Vince Deng
Partner
Med-fine Capital/ SAPA Washington DC-Maryland
Dr. Qijia He
VP
Rongsheng Investment of SNDVC
Dr. Ching Wu
Founder/Chairman of the board/CEO
Excellims Corporation
Dr.Fangfang
Zhu Founder/Chairman of the board/CEO Xueji Bio
Dr. Hua Zhou
CEO
Auhelix
Dr. Hideki Kambara
Professor
Tokyo University of Agriculture and Technology
University of Tokyo
Tokyo Metropolitan University
Nanjing Univeisity
Dr. Kai Qi
CCO
Great Bay Bio
Dr. Hongyu Wang
CTO
GemPharmaTech
Dr. Guohua Zhou
Professor
Nanjing University
Dr.Dajie Tang
CEO
TRI WISE CAPITAL
Dr.Ziheng Zhu
Co Founder
Forry Investment
Drake Yu
Founding Partner,
LYFE Capital
Derek Small
Founding General Manager,
Assembly Biosciences
Research & Development
Co. Shanghai
E
Echo Hindle-Yang
CEO & Founder
MSQ Ventures
Emmanuel Fobum
Johnson & Johnson
Eric Wu
ReiStone Biopharma
F
Fei Tian
Vesalius Biocapital
Feng Tian
Frank Zhang
CEO,
GenScript
G
Gunjan Bhardwaj
Innoplexus AG
Gordon Freeman
Dana-Farber Cancer Center/Harvard Medical School
Gottfried Köhler
European Society for Translational Medicine
Greg Caressi
Foster & Sullivan
Ginger Ding
Director of Research, MyBioGate
George Baeder
Chief Strategy Office,
dMed Global
H
Haishan Xiong
FMD K&L
Harvey Lodish
Whitehead Institute of Biomedical Research/MIT
Herwig Janssen
Janssen Pharmaceutica
Hua Mu
Simcere Pharmaceutical Group
Helen Chen
Greater China Managing Partner, L.E.K. Consulting
Hainian Zeng
CEO,
Silexon AI Technology
I
Irene Hong
Founding Partner, CEC Capital Group
J
Jack Wu
Adlai Nortye Biopharma
James Lee
Atomwise
James Warr
Associate
Greenhill & Co.
James Huang
Jianming Zhao
Hangzhou Municipal Investment Promotion Bureau
Jiawen Han
Qilu Pharmaceutical
Jie (Jay) Liu
Torreya Partners
Jimmy Hao
Fox Rothschild LLP
Jinming Gu
Former Executive Director of Biologics Discovery at Shanghai HengRui Pharmaceuticals
John Chen
John Xu
Jemincare Therapeutics
Jun Bao
Impact Therapeutics
Jonathan Wang
Chairman and CEO, Inmagene Biopharmaceuticals
Jimmy Zhang
Adjunct Professor,
John Jin
Co-founder, D3 BIO
Jeffrey Zhang
Stemirna Therapeutics CEO, CBO; CHBD President
Jasmine Cui
CEO, InnoCare
Jerry Yu
Executive President
Kaitai Capital
GM
IBM GCG Healthcare & Life Sciences
John Lu
Jeremy Guo
Jijie Gu
Chief Scientific Officer and Executive Vice President
WuXi Biologics
Jenny Yang
John Zhu
Partner, 6 Dimensions Capital; Founder and CEO, Duality Biologics
Joan Shen
Senior VP Head, Business
Development,
Zai Lab
Jason Slingsby
CBO,
Oxford Biomedica
K
Katherine Andersen
Silicon Valley Bank
Katherine Cohen
Panacea Venture
Kim Nearing
Konstantin Poukalov
Kenneth Law
Financial Advisory Partner
Life Sciences & Health Care
Deloitte China
Kelvin Shao
VP of Business Development
Kexing Biopharma
L
Laura Benjamin
Oncologie
Lei (Geffrey) Gao
Harbin Pharma
Lijun Wu
Fosun Pharma US
Lily Zou
Fosun Pharma USA
Linda Ji
Lynn Yang
Lin Peng
Director Pharmaceutical Valley
Development
Lyon Wu
Lawyer & Investor
Allbright Law Offices
Larry Cai
Venture Partner
MybioCapital
Luke Chen
General Manager
Beijing YEEDOZENCOM
Healthcare Science &
Technology Co., Ltd.
Lu Cao
US Head of Corporate
Banking for Chinese
Multinationals,J.P. Morgan
Lynnet Koh
CEO,
Targazyme
M
Mark Tang
Good Health Capital
Mark Young
Bridge Point Capital
Martin Dueñas
OniX
Michael Song
MedImmune
Michelle Chen
WuXi Biologics
Miguel Forte
Chair, Commercialization Committee at ISCT
Mark Wesson
CFO, Flow Cell; Mentor, CUBIO Innovation Center
Margaret Wong
Mentor, CUBIO
Innovation Center
N
Nissi Darvish
Noel Goddard
O
Olivier Reinhard
Sanofi
P
Ping Cao
Henlius Biotech
Paul Zhang
Partner, Bluestar
BioAdvisors, LLC
Peng Jiao
CEO, BiBo Biopharma Engineering
Paul E. Burrows
Vice President of Jiangsu
Industrial Technology
Research Institute
Q
Qingping Zeng
Fosun Orinove
Qingxi (Charles) Wang
CSPC Pharmaceutical Group Ltd.
Qun Dang
Qiang Lu
Qi Jin
Managing director,
Kaitai Capital
R
Rachel Sha
Sanofi
Rebecca Robbins
Raymond Tong
CEO, PrimeGen Global
S
Samuel Murphy
Salubris Pharmaceuticals
Sara Chen
Genfleet Therapeutics
Scott Liu
Sean Fu
Luye Boston R&D LLC
Simon Xu
Stefanos Theoharis
Samuel Murphy
CEO, Salubris Biotherapeutics
Shawn Xu
Managing Director and COO, Simcere Innovation
Sizhen Wang
CEO, Genetron
Sara Chen
VP of Business Development
NeoLogics
Sherry Gu
SVP, CMC Management
WuXi Biologics
Seamus Jiang
T
Tom Du
Shenzhen Share Capital
Travis McCready
Tim Xiao
Tong Zhang
Medical Partner
Shenzhen Share Capital
Tianji Zhu
VP
CD Capital
V
Vincent Liu
Senior Advisor & Deputy General Manager, Fosun Pharma Group
W
Wei (William) Cao
Weigang Wang
Weimin Tang
I-Mab Biopharma
Weiwei Liang
Sandoz/Novartis
Wendy Pan
Sidley Austin LLP
Wenjun Sun
VP, Senior Vice
President, Business
Development
JW Therapeutics
Wesley Okeke
CEO, CUBIO
Innovation Center
Wenming Xie
VP
WECAN Medical Group
Weihao Xu
Wei Gan
Zenas Bio SVP
X
Xiangbin (Shawn) Xu
Simcere Innovation, Inc.
Xiangyang (Sean)
Hengrui Therapeutics
Xi-Yong (Sean) Fu
Luye Boston R&D LLC
Xiaoliang Zhang
Partner
Tahoe VC
Y
Yuanhua Ding
Ying Huang
CEO, Legend Biotech
Youzhi Tong
CEO, Kintor
Pharmaceutical
Yinxiang Wang
Chairman and CEO, Jacobio
Pharmaceuticals
Yantao Wang
Managing Director,
Metronic China Fund
Yu Fang
Partner
3E Bioventures Capital
Z
Zengjun (Alex) Xu
CDE/NMPA
Zonghai Li
Zhaolong Gong
